Cargando…

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models

Detalles Bibliográficos
Autores principales:	Peczkowski, Kyra K., Rastogi, Neha, Lowe, Jeovanna, Floyd, Kyle T., Schultz, Eric J., Karaze, Tallib, Davis, Jonathan P., Rafael-Fortney, Jill A., Janssen, Paul M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767497/ https://www.ncbi.nlm.nih.gov/pubmed/35069268 http://dx.doi.org/10.3389/fphys.2021.820245

Ejemplares similares

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2020)

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2015)

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model
por: Howard, Zachary M., et al.
Publicado: (2021)

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2020)

Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy
por: Pant, Meghna, et al.
Publicado: (2015)

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model
por: Piepho, Arden B., et al.
Publicado: (2023)

Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy
por: Howard, Zachary M., et al.
Publicado: (2022)

Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
por: Xu, Jing, et al.
Publicado: (2015)

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Janssen, Paul M. L., et al.
Publicado: (2014)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Medical management of muscle weakness in Duchenne muscular dystrophy
por: Rivera, Sarah R., et al.
Publicado: (2020)

Muscle-Specific SIRT1 Gain-of-Function Increases Slow-Twitch Fibers and Ameliorates Pathophysiology in a Mouse Model of Duchenne Muscular Dystrophy
por: Chalkiadaki, Angeliki, et al.
Publicado: (2014)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies
por: Veeger, Thom T. J., et al.
Publicado: (2021)

Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy
por: Ropars, Juliette, et al.
Publicado: (2016)

Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy
por: Godi, Claudia, et al.
Publicado: (2016)

Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
por: Rugowska, Anna, et al.
Publicado: (2021)

Respiratory Muscle Strength and Cough Capacity in Patients with Duchenne Muscular Dystrophy
por: Kang, Seong-Woong, et al.
Publicado: (2006)

Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
por: Li, Xihua, et al.
Publicado: (2014)

Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
por: Heydemann, Ahlke
Publicado: (2018)

Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model
por: Bajanca, Fernanda, et al.
Publicado: (2017)

Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment
por: Merlini, Luciano, et al.
Publicado: (2020)

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
por: Naarding, Karin J., et al.
Publicado: (2021)

MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy
por: Aránega, Amelia Eva, et al.
Publicado: (2021)

Myosin Binding Protein-C Slow Phosphorylation is Altered in Duchenne Dystrophy and Arthrogryposis Myopathy in Fast-Twitch Skeletal Muscles
por: Ackermann, Maegen A., et al.
Publicado: (2015)

Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status
por: Cruz-Guzmán, Oriana del Rocío, et al.
Publicado: (2015)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
por: Finsterer, Josef, et al.
Publicado: (2016)

A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility
por: Nesmith, Alexander P., et al.
Publicado: (2016)

Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy
por: Dumont, Nicolas A, et al.
Publicado: (2016)

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
por: Łoboda, Agnieszka, et al.
Publicado: (2020)

The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2020)

Inflammation in Duchenne Muscular Dystrophy–Exploring the Role of Neutrophils in Muscle Damage and Regeneration
por: Tulangekar, Ankita, et al.
Publicado: (2021)

Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy
por: Mordechay, Sharon, et al.
Publicado: (2021)

A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy—Not Just a Muscle Defect
por: Coles, Chantal A., et al.
Publicado: (2022)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)

Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
por: Onódi, Zsófia, et al.
Publicado: (2023)

Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing
Publicado: (1995)

Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers
por: Houang, Evelyne M., et al.
Publicado: (2018)

Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
por: Russell, Alan J., et al.
Publicado: (2023)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_87aic11rbemk292ov4b2c2ib2r